Tal Zvi Zaks - May 19, 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: Chief Medical Officer
Signature: /s/ Brian Sandstrom, as Attorney-in-Fact
Stock symbol: MRNA
Transactions as of: May 19, 2021
Transactions value $: -$649,050
Form type: 4
Date filed: 5/20/2021, 05:14 PM
Previous filing: May 13, 2021
Next filing: May 27, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Options Exercise	$130K	+5K		$25.93	5K	May 19, 2021	Direct	F1
transaction	MRNA	Common Stock	Sale	-$779K	-5K	-100%	$155.74	0	May 19, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRNA	Stock Option (Right to Buy)	Options Exercise	$0	-5K	-3.2%	$0.00	151K	May 19, 2021	Common Stock	5K	$25.93	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021.
F2	25% of this option vested and became exercisable on February 28, 2021 with the remainder vesting in twelve (12) equal quarterly installments thereafter.